https://pmc.ncbi.nlm.nih.gov/articles/PMC4115763/

1. Kev xaiv raws li kev kos duab tshwm sim ntawm cov kab mob

• Ultrasound- pom cov khoom loj (Ntau dua lossis sib npaug li 1 cm):CNB txaus rau kev kuaj pom tseeb. Cov txheej txheem txheej txheem suav nrog 2-4 punctures nrog 14G lossis 16G koob nyob rau hauv cov tshuaj loog hauv zos kom sau cov ntaub so ntswg txaus rau kev ntsuas kab mob. Lub caij nplooj ntoos hlav- tsav lub zog ntawm CNB tau yooj yim nkag mus rau cov kab mob ruaj khov xws li kab mob ductal carcinoma.
• Clustered microcalcifications (BI-RADS 4C/5):VABB tau pom zoo. Calcified lesions feem ntau me me thiab tawg, ua random CNB sampling prone rau plam lub hom phiaj. Raws li kev taw qhia stereotactic, VABB ua tiav qhov kev txiav txim siab ntawm tag nrho cov cheeb tsam calcified rau kev kuaj kab mob, xa cov kev kuaj pom tseeb tshaj 98%.
• Tsis yog- cov kab mob loj hlob tuaj pom los ntawm MRI:Tiag tiag - lub sij hawm xav pom koob tsis muaj nyob rau hauv MRI - cov txheej txheem qhia, tsa qhov muag tsis pom kev txaus ntshai rau CNB. Lub tshuab nqus tsev nqus tau ruaj khov cov ntaub so ntswg rau VABB, thiab laser- kos cov cim ntawm lub cannula tseem pom tau meej meej hauv MRI-coils sib xws. VABB tam sim no tsuas yog ib qho kev pom zoo biopsy modality rau MRI kev taw qhia.

2. Kev hloov kho raws li tus neeg mob tshwj xeeb

• Lub mis me me los yog qhov txhab nyob ib sab ntawm lub hauv siab phab ntsa / daim tawv nqaij:Lub caij nplooj ntoo hlav ntev ntawm CNB tuaj yeem ua rau lub hom phiaj ntau dhau, ua rau pneumothorax lossis cutaneous indentation. VABB nta lub tshuab txiav luv luv, thiab lub tshuab nqus tsev tsis zoo rub cov ntaub so ntswg rau hauv kom tsis txhob muaj kev phom sij perforation. VABB koob tsim los ntawm Kev Ua Cuam Tshuam yog tsim los ntawm 316L stainless hlau nrog HRC 30-40 hardness, sib npaug rigidity thiab ductility rau ilv manipulations nyob rau hauv cov ntaub ntawv no.
• Coagulopathy lossis cov neeg mob ntawm cov tshuaj tiv thaiv coagulants: VABB's simultaneous suction-and-cut mechanism compresses microvessels instantly during sampling. Its postoperative hematoma rate (~1.5%) is markedly lower than CNB's (~4%). Multiple clinical guidelines prioritize VABB for patients with INR >1.5.
• Multifocal los yog multicentric lesions:VABB tso cai rau ntau-lub kaum rov ua piv txwv los ntawm ib qho chaw nkag ntawm daim tawv nqaij, qhov CNB xav kom tag nrho repositioning rau txhua qhov puncture. Rau ob sab lesions lossis ntau- kab mob quadrant unilateral, VABB txiav tag nrho cov txheej txheem txheej txheem thiab raug hluav taws xob.

3. Kev sib txuam raws li qhov yuav tsum tau ua rau kev npaj kho mob tom ntej

• Molecular subtyping ua ntej neoadjuvant chemotherapy:VABB yields cov ntaub so ntswg ntau los txhawb IHC kev soj ntsuam rau ER, PR, Ki-67 thiab HER2, ntxiv rau kev sim FISH. Cov qauv CNB feem ntau raug kev txom nyem ntawm cov cellular distortion los ntawm compression, cuam tshuam nrog kev txhais lus pathological.
• Preoperative localization marking rau lub mis npaj -kev txuag kev phais:VABB tso cai rau kev xa tawm ntawm cov hlau nplaum hlau nplaum sib txuam nrog kev kuaj ntshav los coj cov kev phais tom ntej. Qee lub VABB platforms suav nrog cov xov tooj cua zaus ablation, ua rau ib qho - nres kev kuaj mob thiab qhov seem ntawm qhov txhab ablation.
• Ua kom tiav resection ntawm benign lesions:VABB ua raws li cov cuab yeej ua kom muaj qhov cuam tshuam me me rau cov kab mob fibroadenomas lossis papillomas, tshem tawm qhov txhab tag nrho kom tshem tawm qhov xav tau qhib kev phais. CNB tsuas yog khaws qee cov qauv ntaub so ntswg thiab tsis tuaj yeem ua tiav qhov kev txiav txim siab.

Xaus